-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate total amount of expenses directly related to the marketing or selling of products or services.
-
Summary
-
Aytu Biopharma, Inc quarterly/annual Selling and Marketing Expense history and growth rate from 2020 to Q3 2025.
- Aytu Biopharma, Inc Selling and Marketing Expense for the quarter ending September 30, 2025 was $5.32M, a 5.96% decline year-over-year.
- Aytu Biopharma, Inc Selling and Marketing Expense for the twelve months ending September 30, 2025 was $20.6M, a 5% decline year-over-year.
- Aytu Biopharma, Inc annual Selling and Marketing Expense for 2025 was $20.9M, a 5.33% decline from 2024.
- Aytu Biopharma, Inc annual Selling and Marketing Expense for 2024 was $22.1M, a 46.7% decline from 2023.
- Aytu Biopharma, Inc annual Selling and Marketing Expense for 2023 was $41.4M, a 7.07% increase from 2022.
Selling and Marketing Expense, Trailing 12 Months (USD)
Selling and Marketing Expense, Quarterly (USD)
Selling and Marketing Expense, YoY Quarterly Growth (%)
Selling and Marketing Expense, Annual (USD)
Selling and Marketing Expense, YoY Annual Growth (%)